{"id":"https://openalex.org/W4396586927","doi":"https://doi.org/10.1158/1538-7445.sabcs23-tc-01","title":"Abstract TC-01: Baby-TAM Impact on disease progression","display_name":"Abstract TC-01: Baby-TAM Impact on disease progression","publication_year":2024,"publication_date":"2024-05-02","ids":{"openalex":"https://openalex.org/W4396586927","doi":"https://doi.org/10.1158/1538-7445.sabcs23-tc-01"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs23-tc-01","doi":"https://doi.org/10.1158/1538-7445.sabcs23-tc-01","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-tc-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022237789","display_name":"Jack M. Cuzick","orcid":"https://orcid.org/0000-0001-7420-7512","observed_orcids":["https://orcid.org/0000-0001-7420-7512"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Cuzick","raw_affiliation_strings":["1Queen Mary University of London, London, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Queen Mary University of London, London, England, United Kingdom","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053177403","display_name":"Per N Hall","orcid":"https://orcid.org/0000-0002-5640-9126","observed_orcids":["https://orcid.org/0000-0002-5640-9126"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"P. Hall","raw_affiliation_strings":["2Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"9_Supplement","first_page":"TC","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.05689999833703041,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.04989999905228615,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/low-dose-tamoxifen","display_name":"low-dose tamoxifen","score":0.9470000267028809},{"id":"https://openalex.org/keywords/breast-cancer-progression","display_name":"breast cancer progression","score":0.593999981880188},{"id":"https://openalex.org/keywords/ductal-carcinoma-in-situ","display_name":"ductal carcinoma in situ","score":0.9860000014305115},{"id":"https://openalex.org/keywords/lobular-carcinoma-in-situ","display_name":"lobular carcinoma in situ","score":0.9490000009536743},{"id":"https://openalex.org/keywords/atypical-ductal-hyperplasia","display_name":"atypical ductal hyperplasia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/contralateral-breast-cancer","display_name":"contralateral breast cancer","score":0.9549999833106995},{"id":"https://openalex.org/keywords/exemestane","display_name":"exemestane","score":0.7590000033378601},{"id":"https://openalex.org/keywords/breast-density","display_name":"breast density","score":0.7239999771118164},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.514164924621582},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46581459045410156},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.41087424755096436},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34523332118988037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26895418763160706}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs23-tc-01","doi":"https://doi.org/10.1158/1538-7445.sabcs23-tc-01","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.sabcs23-tc-01","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2608397505","https://openalex.org/W2017581146","https://openalex.org/W3000207316","https://openalex.org/W2141052110","https://openalex.org/W3138246439","https://openalex.org/W3133011507","https://openalex.org/W2143486088","https://openalex.org/W6902084784","https://openalex.org/W4393334974","https://openalex.org/W3090740127"],"abstract_inverted_index":{"Abstract":[0],"Professor":[1,32,160,191],"Hall":[2,161],"will":[3,27,124,162,186,283],"have":[4,163],"reviewed":[5,164],"his":[6,165],"studies":[7,166],"on":[8,16,35,43,167,175,194,202,327],"the":[9,29,36,44,168,188,195,203,334],"impact":[10,169],"of":[11,14,31,38,40,47,170,173,190,197,199,206,333],"lower":[12,171],"doses":[13,172],"tamoxifen":[15,41,174,200],"changes":[17,176],"in":[18,118,141,145,177,277,300,304],"breast":[19,82,178,241],"density,":[20,179],"an":[21,180],"important":[22,181],"risk":[23,182],"factor.":[24,183],"Here":[25,184],"I":[26,123,185,282],"review":[28,187],"work":[30,189],"Decensi\u2019s":[33,192],"team":[34,193],"ability":[37,196],"5mg/d":[39,198],"(baby-Tam)":[42,201],"progression":[45,84,204,243,329],"rate":[46,205],"DCIS":[48,88,207,247],"(69%)":[49,208],"and":[50,65,72,87,101,209,224,231,246,260],"other":[51,210],"intraepithelial":[52,211],"lesions":[53,212],"(11%":[54,213],"LCIS,":[55,214],"20%":[56,215],"atypical":[57,216],"ductal":[58,217],"hyperplasia).":[59,218],"This":[60,219],"trial":[61,144,220,303],"involved":[62,221],"500":[63,222],"pre-":[64,223],"postmenopausal":[66,225],"women":[67,226],"randomized":[68,143,227,302],"equally":[69,228],"between":[70,229],"baby-Tam":[71,230],"placebo":[73,232],"with":[74,233],"a":[75,132,142,146,234,291,301,305],"9.7":[76,235],"year":[77,236],"median":[78,237],"follow":[79,238],"up.":[80,239],"All":[81,240],"cancer":[83,242],"(invasive":[85,244],"(77%)":[86,245],"(23%))":[89,248],"was":[90,116,249,275],"reduced":[91,250],"by":[92,104,251,263],"42%":[93,252],"(25":[94,253],"vs":[95,107,254,266],"41":[96,255],"events,":[97,109,256,268],"P":[98,110,257,269],"=":[99,111,258,270],"0.03)":[100,259],"contralateral":[102,261],"tumours":[103,262],"64%":[105,264],"(6":[106,265],"16":[108,267],"0.025).":[112,271],"No":[113,272],"significant":[114,273],"increase":[115,274],"seen":[117,276],"any":[119,278],"side":[120,153,279,312],"effect":[121,280],"(Table).":[122,281],"also":[125,156,284,315],"briefly":[126,285],"discuss":[127,286],"their":[128,287],"new":[129,288],"award":[130,289],"for":[131,152,158,290,311,317],"project":[133,292],"to":[134,138,293,297],"compare":[135,294],"baby":[136,139,295,298],"Tam":[137,296],"exemestane":[140,299],"similar":[147,306],"population":[148,307],"as":[149,308],"above,":[150,309],"initially":[151,310],"effects,":[154,313],"but":[155,314],"subsequently":[157,316],"efficacy.":[159,318],"Citation":[319],"Format:":[320],"J.":[321],"Cuzick,":[322],"P.":[323],"Hall.":[324],"Baby-TAM":[325],"Impact":[326],"disease":[328],"[abstract].":[330],"In:":[331],"Proceedings":[332],"2023":[335,341],"San":[336,344],"Antonio":[337],"Breast":[338],"Cancer":[339,350],"Symposium;":[340],"Dec":[342],"5-9;":[343],"Antonio,":[345],"TX.":[346],"Philadelphia":[347],"(PA):":[348],"AACR;":[349],"Res":[351],"2024;84(9":[352],"Suppl):Abstract":[353],"nr":[354],"TC-01.":[355]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-05-03T00:00:00"}